Biologic pharmacological products, namely, placental derived tissue for use in biological tissue grafts for use in surgery and wound repair, cellular, and molecular products in the nature of human umbilical cord, human amnion, and human placenta for use in medicine, specifically, for use in supplementing cushioning, barrier, and cover functions providing for regenerative, anti-inflammatory, and pro-agiogenesis mechanisms of action. Specific goods commercialized today include: Signature Cord, Signature Matrix, Signature APatch, and Signature AmnioDerm

'action':63 'agiogenesi':60 'amnioderm':77 'amnion':33 'anti':55 'anti-inflammatori':54 'apatch':74 'barrier':47 'biolog':1,11 'cellular':21 'commerci':66 'cord':31,70 'cover':49 'cushion':46 'deriv':6 'function':50 'good':65 'graft':13 'human':29,32,35 'includ':68 'inflammatori':56 'matrix':72 'mechan':61 'medicin':40 'molecular':23 'name':4 'natur':27 'pharmacolog':2 'placent':5 'placenta':36 'pro':59 'pro-agiogenesi':58 'product':3,24 'provid':51 'regen':53 'repair':20 'signatur':69,71,73,76 'specif':41,64 'supplement':45 'surgeri':17 'tissu':7,12 'today':67 'umbil':30 'use':9,15,38,43 'wound':19

ARULUGA SCIENCES, LLC.

Owner

Goods & Services